Since semaglutide is a pure agonist of the GLP-1 receptor, it exclusively stimulates the phenomena controlled by this receptor, while the ability of tirzepatide to act simultaneously on the GLP-1 and GIP receptors enables the activation of all the processes mediated by these incretins (Figure 3)
Weight loss treatment is contraindicated in pregnancy and fetal safety hasn't been established
Eating and Weight Disorders, 20(4), 505-511
Lynn Toohey organizes seminars, acts as a nutritional consultant to Nutri-West (www.nutriwest.com) and authored the Functional Health Evaluation program that analyzes blood tests and DNA raw data (www.FHEcloud.com)
the MHRA warns they may be counterfeit, contaminated, or mislabelled
In Hirschsprungs disease there is a lack of development of nerve cells in the enteric nervous system